Company Details
| Sector | PHARMACEUTICALS |
| Address | 35 - Dockyard Road West Wharf Karachi |
| Auditor | Yousuf Adil, Chartered Accountants |
| Registrar | CDC Share Registrar Services Limited CDC House, 99 - B, Block - B S.M.C.H.S., Main Shahra-e-Faisal Karachi |
| Website | www.pk.gsk.com |
| Fiscal Year | December |
| Details |
Details
GlaxoSmithKline Pakistan Limited is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V.@ incorporated in Netherlands@ whereas its ultimate parent company is GlaxoSmithKline plc@ UK (GSK plc).
Company Announcements
| Date/Time | Announcement |
|---|---|
| 28/04/2021 11:55:23 | PROFIT/LOSS AFTER TAXATION RS. IN MILLION 725.547 FINANCIAL RESULT FOR THE FIRST QUARTER ENDED 31/03/2021 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 1,130.066 EPS = 2.28 |
| 10/03/2021 15:45:29 | PROFIT/LOSS AFTER TAXATION RS. IN MILLION 3,375.240 FINANCIAL RESULT FOR THE YEAR ENDED 31/12/2020 DIVIDEND = 65%(F) PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 4,902.682 EPS = 10.60 ANNUAL GENERAL MEETING WILL BE HELD ON 27/04/2021 BOOK CLOSURE FROM 21/04/2021 BOOK CLOSURE TO 27/04/2021 |
| 29/10/2020 11:57:46 | EPS = 7.44 FINANCIAL RESULT FOR THE NINE MONTHS ENDED 30/09/2020 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 3,769.618 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 2,369.489 |
| 24/08/2020 15:05:26 | PROFIT/LOSS AFTER TAXATION RS. IN MILLION 1,243.348 FINANCIAL RESULT FOR THE HALF YEAR ENDED 30/06/2020 EPS = 3.90 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 1,909.797 |
| 15/05/2020 15:05:21 | EPS = 1.34 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 644.574 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 425.564 FINANCIAL RESULT FOR THE FIRST QUARTER ENDED 31/03/2020 |